vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -178.3%, a 107.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -1.3%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
CTKB vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $78.6M |
| Net Profit | $-44.1M | $-140.1M |
| Gross Margin | 52.9% | 74.2% |
| Operating Margin | -9.0% | -182.2% |
| Net Margin | -70.9% | -178.3% |
| Revenue YoY | 8.1% | 0.4% |
| Net Profit YoY | -557.1% | -3304.1% |
| EPS (diluted) | — | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $78.6M | ||
| Q3 25 | $52.3M | $77.7M | ||
| Q2 25 | $45.6M | $75.6M | ||
| Q1 25 | $41.5M | $77.3M | ||
| Q4 24 | $57.5M | $78.3M | ||
| Q3 24 | $51.5M | $79.1M | ||
| Q2 24 | $46.6M | $74.9M | ||
| Q1 24 | $44.9M | $80.7M |
| Q4 25 | $-44.1M | $-140.1M | ||
| Q3 25 | $-5.5M | $-6.4M | ||
| Q2 25 | $-5.6M | $-102.3M | ||
| Q1 25 | $-11.4M | $-7.9M | ||
| Q4 24 | $9.6M | $-4.1M | ||
| Q3 24 | $941.0K | $3.2M | ||
| Q2 24 | $-10.4M | $-4.1M | ||
| Q1 24 | $-6.2M | $-5.2M |
| Q4 25 | 52.9% | 74.2% | ||
| Q3 25 | 52.7% | 74.4% | ||
| Q2 25 | 52.3% | 75.7% | ||
| Q1 25 | 48.6% | 75.9% | ||
| Q4 24 | 58.5% | 76.3% | ||
| Q3 24 | 56.3% | 77.8% | ||
| Q2 24 | 54.6% | 78.2% | ||
| Q1 24 | 51.3% | 76.2% |
| Q4 25 | -9.0% | -182.2% | ||
| Q3 25 | -17.6% | -3.9% | ||
| Q2 25 | -23.3% | -138.7% | ||
| Q1 25 | -36.1% | -4.7% | ||
| Q4 24 | 5.2% | -1.5% | ||
| Q3 24 | -8.2% | -0.9% | ||
| Q2 24 | -18.3% | -4.6% | ||
| Q1 24 | -23.9% | -3.1% |
| Q4 25 | -70.9% | -178.3% | ||
| Q3 25 | -10.5% | -8.3% | ||
| Q2 25 | -12.2% | -135.2% | ||
| Q1 25 | -27.5% | -10.3% | ||
| Q4 24 | 16.8% | -5.3% | ||
| Q3 24 | 1.8% | 4.1% | ||
| Q2 24 | -22.4% | -5.4% | ||
| Q1 24 | -13.8% | -6.5% |
| Q4 25 | — | $-1.68 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | — | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $341.7M | $484.4M |
| Total Assets | $461.5M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $115.7M | ||
| Q3 25 | $93.3M | $95.7M | ||
| Q2 25 | $75.5M | $162.6M | ||
| Q1 25 | $95.3M | $165.5M | ||
| Q4 24 | $98.7M | $189.5M | ||
| Q3 24 | $162.3M | $168.7M | ||
| Q2 24 | $177.9M | $147.1M | ||
| Q1 24 | $168.8M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | $341.7M | $484.4M | ||
| Q3 25 | $378.6M | $616.9M | ||
| Q2 25 | $377.6M | $633.7M | ||
| Q1 25 | $379.6M | $755.7M | ||
| Q4 24 | $395.7M | $761.3M | ||
| Q3 24 | $385.5M | $754.7M | ||
| Q2 24 | $389.1M | $815.4M | ||
| Q1 24 | $392.6M | $813.8M |
| Q4 25 | $461.5M | $1.2B | ||
| Q3 25 | $494.9M | $1.3B | ||
| Q2 25 | $493.3M | $1.4B | ||
| Q1 25 | $482.6M | $1.5B | ||
| Q4 24 | $499.5M | $1.6B | ||
| Q3 24 | $491.2M | $1.6B | ||
| Q2 24 | $483.7M | $1.5B | ||
| Q1 24 | $492.1M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $23.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $23.2M |
| FCF MarginFCF / Revenue | -2.9% | 29.6% |
| Capex IntensityCapex / Revenue | 1.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $23.3M | ||
| Q3 25 | $-3.9M | $32.2M | ||
| Q2 25 | $108.0K | $33.1M | ||
| Q1 25 | $-125.0K | $2.5M | ||
| Q4 24 | $2.0M | $34.3M | ||
| Q3 24 | $13.2M | $60.1M | ||
| Q2 24 | $6.2M | $31.0M | ||
| Q1 24 | $4.0M | $24.8M |
| Q4 25 | $-1.8M | $23.2M | ||
| Q3 25 | $-4.6M | $32.1M | ||
| Q2 25 | $-1.5M | $33.0M | ||
| Q1 25 | $-974.0K | $2.4M | ||
| Q4 24 | $1.1M | $34.0M | ||
| Q3 24 | $12.2M | $59.8M | ||
| Q2 24 | $5.2M | $30.5M | ||
| Q1 24 | $3.4M | $24.7M |
| Q4 25 | -2.9% | 29.6% | ||
| Q3 25 | -8.7% | 41.3% | ||
| Q2 25 | -3.2% | 43.6% | ||
| Q1 25 | -2.3% | 3.0% | ||
| Q4 24 | 1.9% | 43.5% | ||
| Q3 24 | 23.7% | 75.6% | ||
| Q2 24 | 11.0% | 40.7% | ||
| Q1 24 | 7.6% | 30.6% |
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 0.3% | ||
| Q3 24 | 2.0% | 0.3% | ||
| Q2 24 | 2.3% | 0.6% | ||
| Q1 24 | 1.3% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
